Hexarelin CJC-1295 NO DAC Peptide Stack

The Hexarelin CJC-1295 No DAC Peptide Stack is a dual-peptide research combination supplied at ≥98% purity, manufactured under rigorous analytical standards for qualified laboratory use. This stack pairs two well-characterised growth hormone-related research peptides in a single convenient offering, designed exclusively for in-vitro and preclinical scientific investigation. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Direct Anti Peptide is proud to offer this high-purity Hexarelin CJC-1295 No DAC Peptide Stack to the global research community. This combination brings together two distinct growth hormone secretagogue-class peptides whose complementary mechanisms have made them subjects of significant scientific interest. Researchers studying endocrine signalling, somatotropic axis modulation, and related physiological pathways will find this stack a valuable addition to their experimental toolkit. Both components are provided as individually lyophilised powders, allowing precise and independent handling within laboratory protocols.

Peptide Structure & Amino Acid Sequence

Hexarelin is a synthetic hexapeptide with the amino acid sequence His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂. It functions as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR-1a), triggering downstream signalling cascades associated with somatotroph stimulation in preclinical models. Its compact six-residue structure contributes to its notable receptor binding affinity relative to other peptides in the secretagogue class.

CJC-1295 No DAC (also referred to as Mod GRF 1-29) is a 29-amino acid analogue of endogenous growth hormone-releasing hormone (GHRH). Its sequence is a truncated and stabilised modification of the native GHRH(1-44) molecule, engineered to improve enzymatic resistance and receptor selectivity. Unlike the DAC-containing variant, the No DAC form does not incorporate a drug affinity complex, resulting in a shorter active window more suitable for pulsatile-release research paradigms.

Chemical & Physical Characteristics

• Component 1: Hexarelin — Molecular Formula: C₄₇H₅₈N₁₂O₆, Molecular Weight: ~887.05 g/mol
• Component 2: CJC-1295 No DAC — Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂, Molecular Weight: ~3367.97 g/mol
• Appearance: White to off-white lyophilised powder (both components)
• Solubility: Soluble in aqueous buffer systems under standard laboratory conditions
• Storage State: Lyophilised solid for stability during transit and long-term archiving

Purity & Analytical Verification (HPLC & MS)

Each component of this peptide stack is independently verified to achieve a minimum purity of ≥98% as determined by reverse-phase high-performance liquid chromatography (RP-HPLC). Mass spectrometry (MS) analysis is conducted to confirm correct molecular weight and structural identity, ensuring that both Hexarelin and CJC-1295 No DAC conform precisely to their theoretical profiles. Certificates of Analysis (CoA) reflecting these analytical results are available upon request for every production batch supplied by Direct Anti Peptide.

Quality Control & Lyophilisation Integrity

Both peptides within this stack undergo multi-stage quality control procedures encompassing synthesis validation, purification, and post-lyophilisation testing. Lyophilisation is performed under controlled conditions to remove residual moisture while preserving the three-dimensional integrity of each peptide chain. Residual moisture content and visual appearance are assessed prior to release, ensuring that every vial dispatched from Direct Anti Peptide meets the exacting standards expected by professional researchers and institutional laboratories.

Safety, Handling & Laboratory Precautions

These peptides are intended exclusively for trained laboratory professionals operating within appropriately equipped research facilities. Standard laboratory personal protective equipment (PPE), including gloves, eye protection, and lab coats, should be worn at all times when handling lyophilised or reconstituted peptide material. Researchers should consult applicable institutional biosafety protocols and relevant safety data documentation before commencing work. These compounds are not approved for any human or animal administration and must be handled strictly in accordance with applicable regulatory and institutional guidelines.

Reconstitution, Packaging & Storage

Each peptide component is supplied as a lyophilised powder in individually sealed, clearly labelled vials. Reconstitution should be performed using appropriate research-grade solvents in accordance with the researcher’s validated laboratory protocol. For long-term preservation, vials should be stored at -20°C in a dry, dark environment away from repeated freeze-thaw cycles. Once reconstituted, solutions should be maintained at 2–8°C and used within timeframes consistent with established laboratory best practices. Packaging is designed to maintain product integrity throughout international shipping and storage.

Intended Research Use & Market Positioning

The Hexarelin CJC-1295 No DAC Peptide Stack is positioned as a premium-grade research tool for scientists investigating somatotropic axis biology, GHSR receptor pharmacology, and related endocrine signalling pathways. The complementary mechanisms of these two peptides — one acting via the ghrelin receptor pathway and the other via GHRH receptor engagement — make this stack particularly relevant for studies examining synergistic GH secretion dynamics in controlled preclinical settings. Direct Anti Peptide offers this combination to support reproducible, high-quality research outcomes.

Ordering, Availability & Fulfillment

Researchers and institutions can buy online the Hexarelin CJC-1295 No DAC Peptide Stack directly through Direct Anti Peptide with confidence in product authenticity, analytical traceability, and prompt dispatch. We offer competitive best-price positioning for bulk and repeat research orders, with secure checkout and international fulfillment options. Order now to benefit from our streamlined procurement process and dedicated research customer support team. All orders are subject to verification consistent with our research-use compliance framework.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Hexarelin CJC-1295 No DAC Peptide Stack is sold exclusively as a laboratory research reagent. Direct Anti Peptide assumes no liability for any use of this product outside of its intended research context. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the acquisition, possession, and use of research peptides. This product has not been evaluated by any regulatory authority for safety or efficacy in humans or animals.